A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
about
Triazole linker-based trivalent sialic acid inhibitors of adenovirus type 37 infection of human corneal epithelial cellsEffect of the H1N1 influenza pandemic on the incidence of epidemic keratoconjunctivitis and on hygiene behavior: a cross-sectional study.Five new genome types of adenovirus type 37 caused epidemic keratoconjunctivitis in Sapporo, Japan, for more than 10 years.Structure-based high-throughput epitope analysis of hexon proteins in B and C species human adenoviruses (HAdVs)Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis.Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi ArabiaOutbreak of epidemic keratoconjunctivitis caused by human adenovirus type 56, China, 2012.Complete genome analysis of a novel intertypic recombinant human adenovirus causing epidemic keratoconjunctivitis in Japan.Identification of contamination in the American type culture collection stock of human adenovirus type 8 by whole-genome sequencingNovel human adenovirus causing nosocomial epidemic keratoconjunctivitis.Epidemic keratoconjunctivitis due to the novel hexon-chimeric-intermediate 22,37/H8 human adenovirusAcute bacterial conjunctivitis.Sialic acid tissue distribution and influenza virus tropism.An easy method for preparation of Cre-loxP regulated fluorescent adenoviral expression vectors and its application for direct reprogramming into hepatocytes.Adenoviral load diagnostics by quantitative polymerase chain reaction: techniques and application.Multivalent HSA conjugates of 3'-sialyllactose are potent inhibitors of adenoviral cell attachment and infection.Human Adenovirus Type 37 Uses αVβ1 and α3β1 Integrins for Infection of Human Corneal Cells.Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection.Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953-2013.Genetic variability of human adenovirus type 8 causing epidemic and sporadic cases of keratoconjunctivitis.New genome type of adenovirus serotype 4 caused nosocomial infections associated with epidemic conjunctivitis in JapanMolecular detection and characterization through analysis of the hexon and fiber genes of Adenoviruses causing conjunctivitis in Tunisia, North Africa.Genome variability of human adenovirus type 8 causing epidemic keratoconjunctivitis during 1986-2003 in Japan.Outbreaks of epidemic keratoconjunctivitis caused by human adenovirus type 8 in the Tibet Autonomous Region of China in 2016.Rapid detection of oculopathogenic adenovirus in conjunctivitis.Molecular identification of adenovirus sequences: a rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients.Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.Pediatric adenovirus infection: relationship of clinical spectrum, seasonal distribution, and serotype.Development and assessment of human adenovirus type 11 as a gene transfer vector.Evaluation of sampling technique and transport media for the diagnostics of adenoviral eye infections. Adenovirus sampling and transport.Identification and molecular characterization of adenovirus types (HAdV-8, HAdV-37, HAdV-4, HAdV-3) in an epidemic of keratoconjunctivitis occurred in Pune, Maharashtra, Western India.A 5-year study of adenoviruses causing conjunctivitis in Izmir, Turkey.An outbreak of epidemic keratoconjunctivitis at an outpatient ophthalmology clinic.Activation of nuclear factor-kappa B in the conjunctiva with the epithelial scraping of the mouse cornea and human epidemic keratoconjunctivitisDetection and prevalence of adenoviral conjunctivitis among hospital employees using real-time polymerase chain reaction as an infection prevention tool.Spread of epidemic keratoconjunctivitis due to a novel serotype of human adenovirus in Japan.Molecular epidemiology of adenovirus strains isolated from patients with ocular disease in the area of Thessaloniki, Greece (1998-2002).Feasibility of an antiviral clinical trial requiring cross-country shipment of conjunctival adenovirus cultures and recovery of infectious virus.Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo.
P2860
Q27701560-7F6698EC-44D6-41FF-8BB6-2B2297CF85A9Q30406242-6FE9A1BB-97A0-43BA-B12B-1D6B65E1E486Q33824200-0F74A302-D6BF-4B84-A83F-AE43D33BEF82Q34200191-CBD8E77C-C3D5-4ED9-BB9F-E67AA4444034Q34208227-FC93E334-F656-48DB-AEEA-C87147AA77C6Q34228581-F16A8AF0-18B0-4F98-B39D-3B54BC942D37Q34364541-2865A27D-B607-4D8E-B3A1-6EB198607336Q34400552-FFDB63A2-28BE-4779-8737-6C531289124FQ34596666-B194B155-E6C6-4C2F-A0F0-10ADD92642ECQ36559583-54253B39-3655-4CFD-BF9C-9D96FD9EDC62Q36747493-A4B1D3E4-E58C-40F2-ACB1-BC3FAEAA2DB8Q36933503-173AB8FA-9BFE-427E-88B5-F830DB36ED4AQ36985974-71347E4A-CF0E-4655-8101-5B604E537DCEQ37488386-3CAAF507-E707-4BAC-83EE-70A022B67943Q37714826-7E6C59A8-3582-4F46-8D81-FCD80CB444FEQ37967604-96F43F83-9628-484D-B1D1-3AFAC5E8B41DQ38331292-496934E4-A5D3-4AF7-B9AE-81E6EF54B4C0Q38726189-274602EF-4190-4E6F-BBCF-34A113E0AE81Q38863441-B873BA03-6B24-471A-8207-721B158E65E0Q38924589-8DE88573-EC59-4896-941C-0A95E111C539Q39001225-FC0509EC-F29F-4EDD-A4F3-27C78650C078Q39487659-E3B0FBE2-F8DA-4268-818F-9C0EA90B10F7Q39641192-76A9D70E-5EEC-45DA-8A37-6A10DECE0CA5Q39675538-98F7C656-7DC2-43E9-87EA-85779AE99BF3Q40038780-BC685B8B-7E2E-46C8-954C-C52FCE003379Q40055865-D9DE5373-8630-4AB9-B428-8B99A36696C6Q40254490-DE65EAB4-734F-4C63-A070-B5DFE4777859Q40273995-CD794D56-37B2-46FA-A0EC-254FE22254BDQ40337113-06ECE241-0260-4D23-A834-97AA00729868Q40441928-771DDEB0-DC43-43B3-A559-9DBEBCCCFAE7Q40483400-8D5BDBE9-D1C4-4097-BF58-90A4EFBAF42EQ40684786-471263F2-331D-4E50-A3B4-ED57BA57F995Q41750577-53BE1F05-E481-4C2A-B3D6-F681BD4BE818Q41873093-3E774C1A-E06A-4A5B-BC86-B9593D2B27A3Q42069644-98989D79-1093-4111-BC22-B8305B946E00Q42216499-7E01FC35-EE23-4D49-A1A4-DEA456394146Q43071770-93A415B8-F93D-46AB-8D6C-14B9990155D1Q45222232-148BF9E9-FAD2-4E0C-A1EC-720B03B6B724Q45557404-BAD1D443-C0F0-4BDB-A2ED-661CDE4E8C6AQ47549105-2D8972B3-D946-413A-82A2-BA43DE20A648
P2860
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
@ast
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
@en
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
@nl
type
label
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
@ast
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
@en
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
@nl
prefLabel
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
@ast
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
@en
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
@nl
P1476
A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan.
@en
P2093
Yoshitugu Tagawa
P356
10.1097/00004397-200201000-00008
P577
2002-01-01T00:00:00Z